NUP62 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.072800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.275900E-02
Normal-vs-Stage2
3.148000E-01
Normal-vs-Stage3
2.435800E-01
Normal-vs-Stage4
9.398200E-01
Stage1-vs-Stage2
8.864000E-02
Stage1-vs-Stage3
6.902400E-01
Stage1-vs-Stage4
2.944000E-01
Stage2-vs-Stage3
2.814000E-01
Stage2-vs-Stage4
3.069200E-01
Stage3-vs-Stage4
2.734800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.970400E-01
Normal-vs-AfricanAmerican
3.885800E-01
Normal-vs-Asian
5.034200E-01
Caucasian-vs-AfricanAmerican
9.413800E-01
Caucasian-vs-Asian
6.831600E-01
AfricanAmerican-vs-Asian
8.573200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.829400E-01
Normal-vs-Female
3.575800E-01
Male-vs-Female
5.545600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.478420E-01
Normal-vs-Age(41-60Yrs)
3.385200E-01
Normal-vs-Age(61-80Yrs)
3.357600E-01
Normal-vs-Age(81-100Yrs)
9.811500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.567400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.723000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.254800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.821400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.780000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.855000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.067400E-01
Normal-vs-Daily Drinker
2.526400E-01
Normal-vs-Weekly Drinker
6.409200E-01
Normal-vs-Occasional Drinker
7.764200E-01
Normal-vs-Social Drinker
1.239240E-01
Non Drinker-vs-Daily Drinker
3.604400E-01
Non Drinker-vs-Weekly Drinker
1.046970E-01
Non Drinker-vs-Occasional Drinker
5.703200E-03
Non Drinker-vs-Social Drinker
9.397800E-02
Daily Drinker-vs-Weekly Drinker
3.964200E-01
Daily Drinker-vs-Occasional Drinker
7.154200E-02
Daily Drinker-vs-Social Drinker
6.096400E-01
Weekly Drinker-vs-Occasional Drinker
5.642800E-01
Weekly Drinker-vs-Social Drinker
5.998000E-01
Occasional Drinker-vs-Social Drinker
1.072650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.970800E-01
Normal-vs-Grade 2
9.768400E-01
Normal-vs-Grade 3
9.230000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.096400E-01
Grade 1-vs-Grade 3
2.095400E-01
Grade 1-vs-Grade 4
9.970800E-01
Grade 2-vs-Grade 3
9.664200E-02
Grade 2-vs-Grade 4
9.768400E-01
Grade 3-vs-Grade 4
9.230000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.986620E-01
Normal-vs-NonDiabetic
3.392600E-01
Diabetic-vs-NonDiabetic
2.168000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.970030E-01
Normal-vs-NoPancreatitis
3.038400E-01
Pancreatitis-vs-NoPancreatitis
7.959600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.681200E-01
Normal-vs-N1
3.326200E-01
N0-vs-N1
8.740800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.119800E-01
Normal-vs-TP53-NonMutant
1.803240E-01
TP53-Mutant-vs-TP53-NonMutant
3.740600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
